United Therapeutics Corp
F:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
F:UTH
|
US |
|
Fagerhult AB
F:2F0
|
SE |
|
Ibio Inc
F:0JV
|
US |
|
H
|
Healthequity Inc
F:2HE
|
US |
Wall St Price Targets
UTH Price Targets Summary
United Therapeutics Corp
According to Wall Street analysts, the average 1-year price target for UTH is 459.03 EUR with a low forecast of 351.09 EUR and a high forecast of 530.52 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTH's stock price target?
Price Target
459.03
EUR
According to Wall Street analysts, the average 1-year price target for UTH is 459.03 EUR with a low forecast of 351.09 EUR and a high forecast of 530.52 EUR.
What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for United Therapeutics Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.
What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.
What is the Pre-Tax Income forecast for United Therapeutics Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.
